INSIDER · CIK 1796226
Murphy Andrew J
Co-Chief Scientific Officer at REGENERON PHARMACEUTICALS, INC. (REGN)
↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$3.2MSold on the market
1Companies
Oct 15, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 202616:02 | Oct 14, 2026 | REGNREGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | S · Sell10b5-1 | $772.70 | −4,147 | 47,833 | -8% | −$3.2M | ||
| Oct 15, 202616:02 | Oct 13, 2026 | REGNREGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | M · Exercise10b5-1 | $381.92 | +17,000 | 64,833 | +36% | $6.5M | ||
| Oct 15, 202616:02 | Oct 13, 2026 | REGNREGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | F · Tax10b5-1 | $754.58 | −12,853 | 51,980 | -20% | $9.7M |